{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T12:07:09Z","timestamp":1784635629499,"version":"3.55.0"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T00:00:00Z","timestamp":1554768000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.00745","type":"journal-article","created":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T06:01:40Z","timestamp":1554789700000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":54,"title":["Anti-NT5c1A Autoantibodies as Biomarkers in Inclusion Body Myositis"],"prefix":"10.3389","volume":"10","author":[{"given":"Adam","family":"Amlani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"May Y.","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Tarnopolsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Brady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann E.","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Garcia-De La Torre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Mahler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinrike","family":"Schmeling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire E.","family":"Barber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marvin J.","family":"Fritzler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,4,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1097\/BOR.0000000000000436","article-title":"Inclusion body myositis: advancements in diagnosis, pathomechanisms, and treatment","volume":"29","author":"Schmidt","year":"2017","journal-title":"Curr Opin Rheumatol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1016\/j.clinph.2015.12.011","article-title":"Sporadic inclusion body myositis: a review of recent clinical advances and current approaches to diagnosis and treatment","volume":"127","author":"Needham","year":"2016","journal-title":"Clin Neurophysiol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3233\/JND-160198","article-title":"A systematic review and meta-analysis of prevalence studies of sporadic inclusion body myositis","volume":"4","author":"Callan","year":"2017","journal-title":"J Neuromuscul Dis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/ana.23822","article-title":"Autoantibodies to cytosolic 5\u2032-nucleotidase 1A in inclusion body myositis","volume":"73","author":"Pluk","year":"2013","journal-title":"Ann Neurol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"e20266","DOI":"10.1371\/journal.pone.0020266","article-title":"Autoantibodies against a 43 KDa muscle protein in inclusion body myositis","volume":"6","author":"Salajegheh","year":"2011","journal-title":"PLoS ONE."},{"key":"B6","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1002\/ana.23840","article-title":"Cytosolic 5\u2032-nucleotidase 1A autoimmunity in sporadic inclusion body myositis","volume":"73","author":"Larman","year":"2013","journal-title":"Ann Neurol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1136\/jnnp-2014-310008","article-title":"Seropositivity for NT5c1A antibody in sporadic inclusion body myositis predicts more severe motor, bulbar and respiratory involvement","volume":"87","author":"Goyal","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B8","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1136\/annrheumdis-2014-206691","article-title":"Disease specificity of autoantibodies to cytosolic 5\u2032-nucleotidase 1A in sporadic inclusion body myositis versus known autoimmune diseases","volume":"75","author":"Herbert","year":"2016","journal-title":"Ann Rheum Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/acr.22600","article-title":"Cytosolic 5\u2032-nucleotidase 1A is a common target of circulating autoantibodies in several autoimmune diseases","volume":"68","author":"Lloyd","year":"2015","journal-title":"Arthritis Care Res(Hoboken.)."},{"key":"B10","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/ana.24919","article-title":"Pathomechanisms of anti-cytosolic 5\u2032-nucleotidase 1A autoantibodies in sporadic inclusion body myositis","volume":"81","author":"Tawara","year":"2017","journal-title":"Ann Neurol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1136\/annrheumdis-2016-210282","article-title":"Cytosolic 5\u2032-nucleotidase 1A autoantibody profile and clinical characteristics in inclusion body myositis","volume":"76","author":"Lilleker","year":"2017","journal-title":"Ann Rheum Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cca.2017.07.002","article-title":"Prevalence of anti-NT5C1A antibodies in Japanese patients with autoimmune rheumatic diseases in comparison with other patient cohorts","volume":"472","author":"Muro","year":"2017","journal-title":"Clin Chim Acta."},{"key":"B13","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1136\/annrheumdis-2017-212436","article-title":"Anti-NT5C1A autoantibodies are associated with more severe disease in patients with juvenile myositis","volume":"77","author":"Yeker","year":"2018","journal-title":"Ann Rheum Dis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.3389\/fimmu.2018.01200","article-title":"Autoantibodies to cytosolic 5\u2032-nucleotidase 1A in primary sjogren's syndrome and systemic lupus erythematosus","volume":"9","author":"Rietveld","year":"2018","journal-title":"Front Immunol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.jocn.2014.09.012","article-title":"Inclusion body myositis: a review of clinical and genetic aspects, diagnostic criteria and therapeutic approaches","volume":"22","author":"Mastaglia","year":"2015","journal-title":"J Clin Neurosci."},{"key":"B16","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1517\/17530050802651561","article-title":"Microbead-based technologies in diagnostic autoantibody detection","volume":"3","author":"Fritzler","year":"2009","journal-title":"Expert Opin Med Diag."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymeth.2019.01.007","article-title":"The genesis and evolution of bead-based multiplexing","author":"Graham","year":"2019","journal-title":"Methods."},{"key":"B18","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s13075-017-1380-3","article-title":"Emerging technologies in autoantibody testing for rheumatic diseases","volume":"19","author":"Olsen","year":"2017","journal-title":"Arthritis Res Ther."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1016\/S0140-6736(03)14862-3","article-title":"Diagnostic criteria for polymyositis and dermatomyositis","volume":"362","author":"Miller","year":"2003","journal-title":"Lancet."},{"key":"B20","first-page":"318","article-title":"Redefining dermatomyositis: a description of new diagnostic criteria that differentiate pure dermatomyositis from overlap myositis with dermatomyositis features","volume-title":"Medicine","author":"Troyanov","year":"2014"},{"key":"B21","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJM197502202920807","article-title":"Polymyositis and dermatomyositis (second of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1212\/WNL.0000000000000642","article-title":"Evaluation and construction of diagnostic criteria for inclusion body myositis","volume":"83","author":"Lloyd","year":"2014","journal-title":"Neurology."},{"key":"B23","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis Rheum."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.3899\/jrheum.121204","article-title":"Intraarticular and systemic inflammatory profiles may identify patients with osteoarthritis","volume":"40","author":"Heard","year":"2013","journal-title":"J Rheumatol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s00109-003-0495-y","article-title":"Clinical and serological associations of autoantibodies to GW bodies and a novel cytoplasmic autoantigen GW182","volume":"81","author":"Eystathioy","year":"2003","journal-title":"J Mol Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/S1521-6616(03)00169-4","article-title":"Identification of the B-cell epitopes of the early endosome antigen 1 (EEA1)","volume":"109","author":"Selak","year":"2003","journal-title":"Clin Immunol."},{"key":"B28","first-page":"199","article-title":"Autoantibodies to the survival of motor neuron complex in a patient with necrotizing autoimmune myopathy","volume-title":"Rheumatology","author":"Amlani","year":"2018"},{"key":"B29","doi-asserted-by":"publisher","first-page":"149316","DOI":"10.1155\/2014\/149316","article-title":"Interpretation of ANA indirect immunofluorescence test outside the darkroom using NOVA view compared to manual microscopy","volume":"2014","author":"Copple","year":"2014","journal-title":"J Immunol Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"412","DOI":"10.3389\/fimmu.2015.00412","article-title":"Report of the first international consensus on standardized nomenclature of antinuclear antibody HEp-2 cell patterns 2014-2015","volume":"6","author":"Chan","year":"2015","journal-title":"Front Immunol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1017\/S0317167100016668","article-title":"Functional impairment in patients with sporadic inclusion body myositis","volume":"41","author":"Dunlap","year":"2014","journal-title":"Can J Neurol Sci."},{"key":"B32","doi-asserted-by":"publisher","first-page":"444","DOI":"10.3899\/jrheum.170258","article-title":"The antinuclear antibody test in the diagnosis of antisynthetase syndrome and other autoimmune myopathies","volume":"45","author":"Fritzler","year":"2018","journal-title":"J Rheumatol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"223","DOI":"10.3899\/jrheum.160618","article-title":"A negative antinuclear antibody does not indicate autoantibody negativity in myositis: role of anticytoplasmic antibody as a screening test for antisynthetase syndrome","volume":"44","author":"Aggarwal","year":"2017","journal-title":"J Rheumatol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s11926-018-0738-0","article-title":"New developments in the genetics of inclusion body myositis","volume":"20","author":"Britson","year":"2018","journal-title":"Curr Rheumatol Rep."},{"key":"B35","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1111\/j.1365-3083.2006.01747.x","article-title":"Anti-p97\/VCP antibodies: an autoantibody marker for a subset of primary biliary cirrhosis patients with milder disease?","volume":"63","author":"Miyachi","year":"2006","journal-title":"Scand J Immunol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"e46709","DOI":"10.1371\/journal.pone.0046709","article-title":"Autoantibodies produced at the site of tissue damage provide evidence of humoral autoimmunity in inclusion body myositis","volume":"7","author":"Ray","year":"2012","journal-title":"PLoS ONE."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1002\/art.30349","article-title":"Autoantibodies to survival of motor neuron (SMN) complex in patients with polymyositis\u2013immunoprecipitation of D-E-F-G without other components of small nuclear ribonucleoproteins","volume":"63","author":"Satoh","year":"2011","journal-title":"Arthritis Rheum."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00745\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T06:01:46Z","timestamp":1554789706000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00745\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,9]]},"references-count":37,"alternative-id":["10.3389\/fimmu.2019.00745"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.00745","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,9]]},"article-number":"745"}}